Disclosures for "Clinician Education Initiatives for General Neurologists on ALS: Why It Is Needed and ThinkALS, a Possible Solution"
-
The institution of Dr. Babu has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AI therapeutics. The institution of Dr. Babu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Babu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape. The institution of Dr. Babu has received research support from Biogen. The institution of Dr. Babu has received research support from Novartis. The institution of Dr. Babu has received research support from Ionis. The institution of Dr. Babu has received research support from AI therapeutics.
-
Dr. Yersak has received personal compensation for serving as an employee of Amylyx Pharmceuticals. Dr. Yersak has received personal compensation for serving as an employee of Biogen. Dr. Yersak has received personal compensation for serving as an employee of The ALS Association. Dr. Yersak has stock in Amylyx Pharmaceuticals. Dr. Yersak has stock in Biogen.
-
Dr. Krauss has received personal compensation for serving as an employee of Actuarial Research Corporation.
-
Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. The institution of Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AnnJi. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tsumura. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MediciNova. The institution of Dr. Oskarsson has received research support from Biogen. The institution of Dr. Oskarsson has received research support from Medicinova. The institution of Dr. Oskarsson has received research support from Cytokinetics. The institution of Dr. Oskarsson has received research support from Calico. The institution of Dr. Oskarsson has received research support from Mitsubishi. The institution of Dr. Oskarsson has received research support from Tsumura. The institution of Dr. Oskarsson has received research support from Sanofi. The institution of Dr. Oskarsson has received research support from AZTherapeutics. The institution of Dr. Oskarsson has received research support from Orion. The institution of Dr. Oskarsson has received research support from Esaii.
-
Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samus. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylym. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics.
-
Dr. Lomen-Hoerth has nothing to disclose.
-
Mr. Waldo has nothing to disclose.
-
Ms. Selig has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pfizer. Ms. Selig has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for TriSalus Life Sciences. Ms. Selig has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cytokinetics . Ms. Selig has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Daiichi Sankyo. Ms. Selig has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rising Tide Foundation for Clinical Cancer Research. Ms. Selig has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with ALS Association. Ms. Selig has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with National Brain Tumor Society. Ms. Selig has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Ovarian Cancer Research Alliance. Ms. Selig has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Cholangiocarcinoma Foundation. Ms. Selig has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Target Cancer Foundation. Ms. Selig has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant with LUNGevity Foundation. Ms. Selig has received personal compensation in the range of $10,000-$49,999 for serving as a Meeting Facilitator with International Alliance of ALS/MND Organizations. Ms. Selig has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Cancer Support Community.
-
Ms. Paul has nothing to disclose.
-
-
Neil Thakur has received personal compensation for serving as an employee of The ALS Association. An immediate family member of Neil Thakur has received publishing royalties from a publication relating to health care.